相关实验视频

Updated: Jan 11, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

纤维素替代的主要出血的进展:从案例系列的见解

David S Shapiro¹, Daniel Katz², John J Kowalczyk³

¹Department of Surgery, University of Connecticut School of Medicine, Farmington, USA.

|November 14, 2025

概括

在心脏病,产科和创伤患者中,及时补充纤维素对管理严重出血至关重要. 使用纤维素缩物或减少病原体的冷沉积物可以快速恢复凝块的稳定性并改善结果.

科学领域:

血液学血液学血液学
关键护理医学关键护理医学
麻醉学麻醉学

背景情况:

获得的纤维素缺乏症 (AFD) 在严重出血期间会损害血液静止.
凝块的稳定性受到低纤维素素水平的损害.
关键出血的有效管理需要解决AFD.

研究的目的:

在不同临床环境中探索纤维素替代在重大出血中的作用.
评估使用纤维素缩物 (FC) 和减少病原体的冷沉积物 (PRC) 来管理获得的纤维素缺乏症.
审查关键出血的最佳治疗策略,包括粘弹性测试 (VET).

主要方法:

一系列病例检查了三个不同的临床情景:心脏手术,产后出血和创伤引起的凝血病.
使用FC或PRC作为标准冷沉积物的替代品进行纤维素重复.
以粘弹性测试 (VET) 结果为指导的治疗选择的审查.

主要成果:

用FC或PRC快速补充纤维素被用于管理外科手术期间出血.
这些干预措施旨在恢复AFD患者的凝块稳定性.
粘弹性测试 (VET) 被认为是指导治疗决策.

结论:

及时补充纤维素素是管理关键出血的必要条件.
FC和PRC为快速纤维素补充提供了可行的选择.
粘弹性测试 (VET) 可以帮助优化纤维素素替代策略.

关键词:

麻醉学麻醉学流血出血流血出血流血和血液制品的使用心脏外科手术的心脏手术纤维素原体是有纤维的产科出血产科出血复苏复苏复苏复苏复苏复苏复苏复苏创伤性出血是一种创伤性出血.

更多相关视频

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

Microfluidics in Assessing Platelet Function

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Clot Retraction and Fibrinolysis

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

Introduction to Hemostasis

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...